RxDoctor Payments Data

Jeffrey Gelfand, MD

Hand Surgery · Annapolis, MDNPI 1790787851

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,431 of the $1,890 with a category attached, or 75.7%. Medartis Inc. accounts for 75.7% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $972 and has fallen 91.9% since, to $79 in 2025.

$1,890in general payments, 2019–2025

Across 9 payments — averaging $209.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medartis Inc.$1K
  • Globus Medical$277
  • Smith+Nephew$124
  • Zimmer Biomet$41
  • Amgen$18

What the payments were for

  • Royalty or licence$1,43176%
  • Food & beverage$45924%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medartis Inc.2$1,431
Globus Medical(2 entities)2$277
Smith+Nephew3$124
Zimmer Biomet1$41
Amgen1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,890 in reported general payments places this provider in the 55th percentile of 54 hand surgery providers in Maryland.

See all hand surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$285,689
Medicare patients
859
Services billed
2,513

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium11$122
Meloxicam17$87
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$50

Paid to pharmacies, not to this prescriber.

Other hand surgery in Annapolis

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →